Thompson Elizabeth H.Z.
SEC insider (Form 3/4/5 filer). CIK 0001861477. EVP, Head of Research & Dev at ACADIA PHARMACEUTICALS INC (ACAD) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Jul 30, 2026. Located in SAN DIEGO, CA.
Companies Thompson Elizabeth H.Z. has filed insider reports for
- ACADIA PHARMACEUTICALS INC (ACAD): Officer, EVP, Head of Research & Dev
- IGM Biosciences, Inc. (IGMS): Director
Thompson Elizabeth H.Z.
CIK: 0001861477
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jul 30, 2026ACAD
ACADIA PHARMACEUTICALS INC
SaleDirect50 shares at avg. $26.17$1K - Jul 30, 2026ACAD
ACADIA PHARMACEUTICALS INC
SaleDirect16.5K shares at avg. $26.13$431K - Jul 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect32.3K shares- - Mar 25, 2026ACAD
ACADIA PHARMACEUTICALS INC
SaleDirect3.4K shares at avg. $21.47$74K - Mar 24, 2026ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect6.7K shares- - Mar 6, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
29.5K shares- - Mar 6, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
101.6K shares- - Aug 14, 2025IGMS
IGM Biosciences, Inc.
DispositionDirect7.2K shares- - Jun 30, 2025IGMS
IGM Biosciences, Inc.
AwardDirect694 shares- - Mar 31, 2025IGMS
IGM Biosciences, Inc.
AwardDirect694 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 30, 2026 |  ACAD ACADIA PHARMACEUTICALS INC | Sale | 50 | $26.17 | $1,309 | Direct |
| Jul 30, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Sale | 16,508 | $26.13 | $431,354 | Direct |
| Jul 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 32,272 | - | $0 | Direct |
| Mar 25, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Sale | 3,435 | $21.47 | $73,749 | Direct |
| Mar 24, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 6,715 | - | $0 | Direct |
| Mar 6, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 29,548 | - | - | Direct |
| Mar 6, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 101,574 | - | - | Direct |
| Aug 14, 2025 |  IGMS IGM Biosciences, Inc. | Disposition | 7,196 | - | - | Direct |
| Jun 30, 2025 | IGMS IGM Biosciences, Inc. | Award | 694 | - | - | Direct |
| Mar 31, 2025 | IGMS IGM Biosciences, Inc. | Award | 694 | - | - | Direct |
1-10 of 14 transactions